Introducing DOCTOR BILLIONS: What if your sur...

For two years, Elizabeth Holmes enjoyed the type of glowing media coverage most entrepreneurs can only dream of. But then she gave one interview too many—an interview with The New Yorker’s Ken Auletta that planted the seeds of her downfall. Learn more about your ad choices. Visit ...  Show more

Host John Carreyrou and reporter Emily Saul discuss prosecutors' introduction of private texts between Elizabeth and Sunny, the testimony of retired general James Mattis, and the trial's most important witness so far: former lab director Adam Rosendorff, who said Theranos priorit ...  Show more

This week, Elizabeth Holmes returns to the stand, presenting herself as a confident CEO with a noble mission who also naively took experts at their word. She meticulously details how she built her business -- even admitting to having doctored those pharmaceutical documents -- but ...  Show more

Elizabeth Holmes has been found guilty of fraud. We ask what lessons her downfall holds for Theranos’s high-profile backers—and for a startup culture of hype before science. As Apple crosses a $3trn valuation we examine the motives for its stop-start forays into the competitiv ...

As Elizabeth Holmes awaits a criminal trial, how is she spending her days? A former employee who had a chance encounter tells us some surprising new details about just that, while an old classmate emerges to share some insight into her past. Plus former U.S. Attorney for the Sout ...  Show more